{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:31:52Z","timestamp":1794000712439,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]},{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]},{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]},{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]},{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]},{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]},{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]},{"name":"Partial financial support will be received from the Deanship of Scientific Research , King Saud University, Saudi Arabia, Riyadh","award":["Grant No. URSP-4-19-129"],"award-info":[{"award-number":["Grant No. URSP-4-19-129"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myocardial infarction (MI) is considered a public health problem. According to the World Health Organization, MI is a leading cause of death and comorbidities worldwide. Activation of the \u03b11A adrenergic receptor is a contributing factor to the development of MI. Tamsulosin, an \u03b11A adrenergic blocker, has gained wide popularity as a medication for the treatment of benign prostatic hyperplasia. Limited evidence from previous studies has revealed the potential cardioprotective effects of tamsulosin, as its inhibitory effect on the \u03b11A adrenoceptor protects the heart by acting on the smooth muscle of blood vessels, which results in hypotension; however, its effect on the infarcted heart is still unclear. The mechanisms of the expected cardioprotective effects mediated by tamsulosin are not yet understood. Transforming growth factor-beta (TGF-\u03b2), a mediator of fibrosis, is considered an attractive therapeutic target for remodeling after MI. The role of \u03b11A adrenoceptor inhibition or its relationships with integrin-linked kinase (ILK) and TGF-\u03b2\/small mothers against decapentaplegic (Smad) signaling pathways in attenuating MI are unclear. The present study was designed to investigate whether tamsulosin attenuates MI by modulating an ILK-related TGF-\u03b2\/Smad pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-four adult male Wistar rats were randomly divided into 4 groups: control, ISO, TAM, and ISO\u2009+\u2009TAM. ISO (150\u00a0mg\/kg, intraperitoneally) was injected on Days 20 and 21 to induce MI. Tamsulosin (0.8\u00a0mg\/kg, orally) was administered for 21\u00a0days, prior to ISO injection for 2 consecutive days. Heart-to-body weight ratios and cardiac and fibrotic biomarker levels were subsequently determined. ILK, TGF-\u03b21, p-Smad2\/3, and collagen III protein expression levels were determined using biomolecular methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Tamsulosin significantly attenuated the relative heart-to-body weight index (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.5) and creatine kinase-MB level (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) compared with those in the ISO control group. While ISO resulted in superoxide anion production and enhanced oxidative damage, tamsulosin significantly prevented this damage through antioxidant defense mechanisms, increasing glutathione and superoxide dismutase levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and decreasing lipid peroxide oxidation levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). The present data revealed that tamsulosin reduced TGF-\u03b2\/p-Smad2\/3 expression and enhanced ILK expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tamsulosin may exert a cardioprotective effect by modulating the ILK-related TGF-\u03b2\/Smad signaling pathway. Thus, tamsulosin may be a useful therapeutic approach for preventing MI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03188-w","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T02:05:34Z","timestamp":1679623534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["\u03b11A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase\/TGF-\u03b2\/Smad signaling pathways"],"prefix":"10.1186","volume":"23","author":[{"given":"Nawal M.","family":"Alrasheed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad B.","family":"Alammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahani K.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-0840","authenticated-orcid":false,"given":"Maha A.","family":"Alamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer O.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma S.","family":"Alonazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anfal F.","family":"Bin Dayel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf M.","family":"Alrasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"3188_CR1","unstructured":"Heart-Health Screenings. www.Heart.org. 2021. Available from: https:\/\/www.heart.org\/en\/health-topics\/consumer-healthcare\/what-is-cardiovascular-disease\/heart-health-screenings."},{"key":"3188_CR2","first-page":"47","volume":"7","author":"M Moradi-Arzeloo","year":"2016","unstructured":"Moradi-Arzeloo M, Farshid AA, Tamaddonfard E, Asri-Rezaei S. Effects of histidine and vitamin C on isoproterenol-induced acute myocardial infarction in rats. Vet Res Forum. 2016;7:47\u201354.","journal-title":"Vet Res Forum"},{"key":"3188_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2013.04.004","volume":"229","author":"H Wang","year":"2013","unstructured":"Wang H, Eitzman D. Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis. 2013;229:18\u201322.","journal-title":"Atherosclerosis"},{"key":"3188_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.7150\/ijms.9623","volume":"11","author":"MJ Hung","year":"2014","unstructured":"Hung MJ, Hu P, Hung MY. Coronary artery spasm: Review and update. Int J Med Sci. 2014;11:1161\u201371.","journal-title":"Int J Med Sci"},{"key":"3188_CR5","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1161\/ATVBAHA.115.305919","volume":"35","author":"X Zhao","year":"2015","unstructured":"Zhao X, Balaji A, Pachon R, Beniamen D, Vatner D, Graham R, et al. Overexpression of cardiomyocyte \u03b11A-adrenergic receptors attenuates postinfarct remodeling by inducing angiogenesis through heterocellular signaling. Arterioscler Thromb Vasc Biol. 2015;35:2451\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3188_CR6","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3892\/etm.2017.4162","volume":"13","author":"W Lu","year":"2017","unstructured":"Lu W, Xie J, Gu R, Xu B. Expression of integrin-linked kinase improves cardiac function in a swine model of myocardial infarction. Exp Ther Med. 2017;13:1868\u201374.","journal-title":"Exp Ther Med"},{"key":"3188_CR7","first-page":"2464","volume":"48","author":"Y Wu","year":"2011","unstructured":"Wu Y, Yin X, Wijaya C, Huang MH, McConnell BK. Acute myocardial infarction in rats. J Vis Exp. 2011;48:2464.","journal-title":"J Vis Exp"},{"key":"3188_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","volume":"114","author":"T Oka","year":"2014","unstructured":"Oka T, Akazawa H, Naito A, Komuro I. Angiogenesis and Cardiac Hypertrophy. Circ Res. 2014;114:565\u201371.","journal-title":"Circ Res"},{"key":"3188_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"565","author":"V Talman","year":"2016","unstructured":"Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 2016;565:563\u201381.","journal-title":"Cell Tissue Res"},{"key":"3188_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","volume":"70","author":"A Shinde","year":"2014","unstructured":"Shinde A, Frangogiannis N. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol. 2014;70:74\u201382.","journal-title":"J Mol Cell Cardiol"},{"key":"3188_CR11","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1084\/jem.20060807","volume":"203","author":"G Mahabeleshwar","year":"2006","unstructured":"Mahabeleshwar G, Feng W, Phillips D, Byzova T. Integrin signaling is critical for pathological angiogenesis. J Exp Med. 2006;203:2495\u2013507.","journal-title":"J Exp Med"},{"key":"3188_CR12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","volume":"285","author":"F Giancotti","year":"1999","unstructured":"Giancotti F, Ruoslahti E. Integrin signaling. Science. 1999;285:1028\u201332.","journal-title":"Science"},{"key":"3188_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1050-1738(03)00142-7","volume":"13","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ, Lebrin F, Valdimarsdottir G. Controlling the angiogenic switch: a balance between two distinct TGF-\u03b2 receptor signaling pathways. Trends Cardiovasc Med. 2003;13:301\u20137.","journal-title":"Trends Cardiovasc Med"},{"key":"3188_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2006","unstructured":"Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2006;74:184\u201395.","journal-title":"Cardiovasc Res"},{"key":"3188_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0735-1097(01)01518-2","volume":"38","author":"CM Yu","year":"2001","unstructured":"Yu CM, Tipoe GL, Wing-Hon Lai K, Lau CP. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol. 2001;38:1207\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"3188_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4049\/jimmunol.1300272","volume":"194","author":"D Nurgazieva","year":"2015","unstructured":"Nurgazieva D, Mickley A, Moganti K, Ming W, Ovsyi I, Popova A, et al. TGF beta1, but not bone morphogenetic proteins, activates Smad1\/5 pathway in primary human macrophages and induces expression of proatherogenic genes. J Immunol. 2015;194:709\u201318.","journal-title":"J Immunol"},{"key":"3188_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.RES.0000022200.71892.9F","volume":"90","author":"I Shiojima","year":"2002","unstructured":"Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002;90:1243\u201350.","journal-title":"Circ Res"},{"key":"3188_CR18","first-page":"312","volume":"7","author":"R Gu","year":"2012","unstructured":"Gu R, Bai J, Ling L, Ding L, Zhang N, Ye J, et al. Increased expression of integrin-linked kinase improves cardiac function and decreases mortality in dilated cardiomyopathy model of rats. PLoS ONE. 2012;7:312\u201379.","journal-title":"PLoS ONE"},{"key":"3188_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/FJC.0000000000000032","volume":"63","author":"BC Jensen","year":"2014","unstructured":"Jensen BC. O\u02bcConnell TD, Simpson PC: Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation. J Cardiovasc Pharmacol. 2014;63:291\u2013301.","journal-title":"J Cardiovasc Pharmacol"},{"key":"3188_CR20","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.juro.2009.02.034","volume":"181","author":"LS Marks","year":"2009","unstructured":"Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Rapid efficacy of the highly selective alpha-1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3. J Urol. 2009;181:2634\u201340.","journal-title":"J Urol"},{"key":"3188_CR21","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/j.1464-410X.2011.10233.x","volume":"108","author":"HJ Yu","year":"2011","unstructured":"Yu HJ, Lin A, Yang S, Tsui KH, Wu HC, Cheng CL, et al. Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). BJU Int. 2011;108:1843\u20138.","journal-title":"BJU Int"},{"key":"3188_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2710.2002.00382.x","volume":"27","author":"Y Miyazawa","year":"2002","unstructured":"Miyazawa Y, Paul Starkey L, Forrest A, Schentag JJ, Kamimura H, Swarz H, Ito Y. Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (Lanoxin) in normal healthy subjects: a placebo-controlled evaluation. J Clin Pharm Ther. 2002;27:13\u20139.","journal-title":"J Clin Pharm Ther."},{"key":"3188_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/toxsci\/61.2.224","volume":"61","author":"SD Pingree","year":"2001","unstructured":"Pingree SD, Simmonds PL, Woods JS. Effects of 2,3-dimercapto-1-propanesulfonic Acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats. Toxicol Sci. 2001;61:224\u201333.","journal-title":"Toxicol Sci"},{"key":"3188_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre J, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem Biophys Acta. 1979;582:67\u201378.","journal-title":"Biochem Biophys Acta"},{"key":"3188_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351\u20138.","journal-title":"Anal Biochem"},{"key":"3188_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jcp.29.1.73","volume":"29","author":"A Delides","year":"1976","unstructured":"Delides A, Spooner RJ, Goldberg DM, Neal FE. An optimized semi-automatic rate method for serum glutathione reductase activity and its application to patients with malignant disease. J Clin Pathol. 1976;29:73\u20137.","journal-title":"J Clin Pathol"},{"key":"3188_CR27","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","volume":"76","author":"H Towbin","year":"1979","unstructured":"Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Sci USA. 1979;76:4350\u20134.","journal-title":"Proc Natl Sci USA"},{"key":"3188_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0031-6865(99)00030-8","volume":"74","author":"JP Hieble","year":"2000","unstructured":"Hieble JP. Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics. Pharm Acta Helv. 2000;74:163\u201371.","journal-title":"Pharm Acta Helv"},{"key":"3188_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0014-2999(97)01465-9","volume":"342","author":"JA Garcia-Sainz","year":"1998","unstructured":"Garcia-Sainz JA, Alcantara-Hernandez R, Vazquez-Prado J. \u03b11-Adrenoceptor subtype activation increases proto-oncogene mRNA levels. Role of protein kinase C. Eur J Pharmacol. 1998;342:331\u2013317.","journal-title":"Eur J Pharmacol."},{"key":"3188_CR30","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1074\/jbc.271.10.5839","volume":"271","author":"DG Rokosh","year":"1996","unstructured":"Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA, et al. \u03b11-Adrenergic receptor subtype mRNAs are differentially regulated by \u03b11-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. J Biol Chem. 1996;271:5839\u201343.","journal-title":"J Biol Chem"},{"key":"3188_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0014-2999(96)00442-6","volume":"312","author":"HT Yang","year":"1996","unstructured":"Yang HT, Endoh M. (\u00b1)-Tamsulosin, an \u03b11A-adrenoceptor antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart. Eur J Pharmacol. 1996;312:281\u201391.","journal-title":"Eur J Pharmacol"},{"key":"3188_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/BF00515552","volume":"328","author":"KT Honda","year":"1985","unstructured":"Honda KT, Takenaka A, Miyata-Osawa M, Terai K, Shiono T. Studies on YM-12617: a selective and potent antagonist of postsynaptic \u03b11-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1985;328:264\u201372.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"3188_CR33","first-page":"S22","volume":"7","author":"CR Chapple","year":"2005","unstructured":"Chapple CR. A comparison of varying alpha-blockers and other pharmacotherapy options for lower urinary tract symptoms. Rev Urol. 2005;7:S22\u201330.","journal-title":"Rev Urol"},{"key":"3188_CR34","first-page":"339","volume":"59","author":"WW Brooks","year":"2009","unstructured":"Brooks WW, Conrad CH. Isoproterenol-induced myocardial injury and diastolic dysfunction in mice structure and functional correlate. Comp Med. 2009;59:339\u201343.","journal-title":"Comp Med"},{"key":"3188_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3923\/jpt.2011.1.17","volume":"6","author":"A Upaganlawar","year":"2011","unstructured":"Upaganlawar A, Gandhi H, Balaraman R. Isoproterenol induced myocardial infarction: protective role of natural products. J Pharmacol Toxicol. 2011;6:1\u201317.","journal-title":"J Pharmacol Toxicol"},{"key":"3188_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/aps.2010.231","volume":"32","author":"B Guo","year":"2011","unstructured":"Guo B, Li YJ, Han R, Yang SL, Shi YH, Han DR, et al. Telmisartan attenuates isoproterenol-induced cardiac remodeling in rats via regulation of cardiac adiponectin expression. Acta Pharmacol Sin. 2011;32:449\u201355.","journal-title":"Acta Pharmacol Sin"},{"key":"3188_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cvr\/21.4.248","volume":"21","author":"T Kondo","year":"1987","unstructured":"Kondo T, Ogawa Y, Sugiyama S, Ito T, Satake T, Ozawa T. Mechanism of isoproterenol induced myocardial damage. Cardiovasc Res. 1987;21:248\u201354.","journal-title":"Cardiovasc Res"},{"key":"3188_CR38","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1006\/jmcc.1997.0508","volume":"29","author":"RK Kudej","year":"1997","unstructured":"Kudej RK, Iwase M, Uechi M, Vatner DE, Oka N, Ishikawa Y, et al. Effects of chronic beta-adrenergic receptor stimulation in mice. J Mol Cell Cardiol. 1997;29:2735\u201346.","journal-title":"J Mol Cell Cardiol"},{"key":"3188_CR39","doi-asserted-by":"publisher","first-page":"112037","DOI":"10.1016\/j.jep.2019.112037","volume":"242","author":"ET Paulino","year":"2019","unstructured":"Paulino ET, Ferreira AKB, Da Silva JCG, Costa CDF, Smaniotto S, De Ara\u0171jo-J\u0171nior JX, et al. Cardioprotective effects induced by hydroalcoholic extract of leaves of alpinia\n zerumbet on myocardial infarction in rats. J Ethnopharmacol. 2019;242:112037.","journal-title":"J Ethnopharmacol"},{"key":"3188_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1656450","volume":"2016","author":"G Kurian","year":"2016","unstructured":"Kurian G, Rajagopal R, Vedantham S, Rajesh M. The Role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited. Oxid Med Cell Longev. 2016;2016:1\u201314.","journal-title":"Oxid Med Cell Longev"},{"key":"3188_CR41","doi-asserted-by":"publisher","first-page":"e91877","DOI":"10.1371\/journal.pone.0091877","volume":"9","author":"A Davel","year":"2014","unstructured":"Davel A, Brum P, Rossoni L. Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gi\u03b1-coupled \u03b22-adrenoceptor signaling pathway. PLoS ONE. 2014;9:e91877.","journal-title":"PLoS ONE"},{"key":"3188_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0008-6363(98)00244-2","volume":"40","author":"PK Singal","year":"1998","unstructured":"Singal PK, Khaper N, Palace V, Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res. 1998;40:426\u201332.","journal-title":"Cardiovasc Res"},{"key":"3188_CR43","first-page":"10139","volume":"8","author":"H Chen","year":"2015","unstructured":"Chen H, Xu Y, Wang J, Zhao W, Ruan H. Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation and oxidative stress in rat. Int J Clin Exp Pathol. 2015;8:10139\u201347.","journal-title":"Int J Clin Exp Pathol"},{"key":"3188_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000496800","volume":"103","author":"Y Fan","year":"2019","unstructured":"Fan Y. Cardioprotective effect of rhapontigenin in isoproterenol-induced myocardial infarction in a rat model. Pharmacology. 2019;103:291\u2013302.","journal-title":"Pharmacology"},{"key":"3188_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","volume":"65","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70\u201399.","journal-title":"Mol Aspects Med"},{"key":"3188_CR46","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3892\/etm.2013.935","volume":"5","author":"HC Gao","year":"2013","unstructured":"Gao HC, Zhao H, Zhang WQ, Li YQ. The role of the Rho\/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models. Exp Ther Med. 2013;5:1123\u20138.","journal-title":"Exp Ther Med"},{"key":"3188_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.yexmp.2009.10.011","volume":"88","author":"W Feng","year":"2010","unstructured":"Feng W, Li W. The study of ISO induced heart failure rat model. Exp Mol Pathol. 2010;88:299\u2013304.","journal-title":"Exp Mol Pathol"},{"key":"3188_CR48","first-page":"1","volume":"2019","author":"Q Wang","year":"2019","unstructured":"Wang Q, Yu X, Xu H, Zhao X, Sui D. Ginsenoside re improves isoproterenol-induced myocardial fibrosis and heart failure in rats. Evid Based Complement Alternat Med. 2019;2019:1\u20139.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3188_CR49","first-page":"1573","volume":"41","author":"X Wu","year":"2018","unstructured":"Wu X, Li M, Chen SQ, Li S, Guo F. Pin1 facilitates isoproterenol-induced cardiac fibrosis and collagen deposition by promoting oxidative stress and activating the MEK1\/2-ERK1\/2 signal transduction pathway in rats. Intl J Mol Med. 2018;41:1573\u201383.","journal-title":"Intl J Mol Med"},{"key":"3188_CR50","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/01.RES.65.3.657","volume":"65","author":"I Benjamin","year":"1989","unstructured":"Benjamin I, Jalil J, Tan L, Cho K, Weber K, Clark W. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657\u201370.","journal-title":"Circ Res"},{"key":"3188_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1871529X11313020010","volume":"13","author":"Y Purnomo","year":"2013","unstructured":"Purnomo Y, Piccart Y, Coenen T, Prihadi J, Lijnen P. Oxidative stress and transforming growth factor-\u03b2-induced cardiac fibrosis. Cardiovasc Hematol Disord Drug Targets. 2013;13:165\u201372.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"3188_CR52","doi-asserted-by":"publisher","first-page":"14892","DOI":"10.1096\/fj.202000737RRR","volume":"34","author":"H Ren","year":"2020","unstructured":"Ren H, Zuo S, Hou Y, Shang W, Liu N, Yin Z. Inhibition of \u03b11-adrenoceptor reduces TGF-\u03b21-induced epithelial-to-mesenchymal transition and attenuates UUO-induced renal fibrosis in mice. FASEB J. 2020;34:14892\u2013904.","journal-title":"FASEB J"},{"key":"3188_CR53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00109-015-1251-9","volume":"93","author":"K Okumura","year":"2015","unstructured":"Okumura K, Kato H, Honjo O, Breitling S, Kuebler WM, Sun M, et al. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension. J Mol Med (Berl). 2015;93:663\u201374.","journal-title":"J Mol Med (Berl)"},{"key":"3188_CR54","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1161\/01.RES.0000265233.40455.62","volume":"100","author":"GE Hannigan","year":"2007","unstructured":"Hannigan GE, Coles JG, Dedhar S. Inegrin-linked kinase at heart of cardiac contractility, repair, and disease. Cir Res. 2007;100:1408\u201314.","journal-title":"Cir Res"},{"key":"3188_CR55","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1101\/gad.1458906","volume":"20","author":"DE White","year":"2006","unstructured":"White DE, Coutu P, Shi YF, Tardif JC, Nattel S, Arnaud RS, et al. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev. 2006;20:2355\u201360.","journal-title":"Genes Dev"},{"key":"3188_CR56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.yjmcc.2015.11.010","volume":"93","author":"C Chen","year":"2016","unstructured":"Chen C, Li R, Ross RS, Manso AM. Integrins and integrin-related proteins in cardiac fibrosis. J Mol Cell Cardiol. 2016;93:162\u201374.","journal-title":"J Mol Cell Cardiol"},{"key":"3188_CR57","first-page":"124","volume":"103","author":"RR Sofia","year":"2014","unstructured":"Sofia RR, Serra AJ, Silva JA, Antonio EL, Manchini L. Gender-based differences in cardiac remodeling and ILK expression after myocardial infarction. Arq Bras Cardiol. 2014;103:124\u201330.","journal-title":"Arq Bras Cardiol"},{"key":"3188_CR58","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.109.870725","volume":"120","author":"L Ding","year":"2009","unstructured":"Ding L, Dong L, Chen X, Zhang L, Xu X, Ferro A, et al. Increased expression of integrin-linked kinase attenuation left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation. 2009;120:764\u201373.","journal-title":"Circulation"},{"key":"3188_CR59","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/labinvest.3700345","volume":"85","author":"H Chen","year":"2005","unstructured":"Chen H, Huang XN, Yan W, Chen K, Guo L, Tummalapali L, et al. Role of the integrin-linked kinase\/PINCH1\/alpha-parvin complex in cardiac myocyte hypertrophy. Lab Invest. 2005;85:1342\u201356.","journal-title":"Lab Invest"},{"key":"3188_CR60","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.106.642330","volume":"114","author":"H Lu","year":"2006","unstructured":"Lu H, Fedak PW, Dai X, Du C, Zhou YQ, Henkelman M, et al. Integrin-linked kinase expression Is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation. 2006;114:2271\u20139.","journal-title":"Circulation"},{"key":"3188_CR61","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2119\/molmed.2015.00059","volume":"21","author":"JL Cano-Pe\u0144alver","year":"2016","unstructured":"Cano-Pe\u0144alver JL, Griera M, Garc\u020ba-Jerez M, Hatem-Vaquero M, Ruiz-Torres MP, Rodr\u00ecguez-Puyol D, et al. Renal integrin-linked kinase depletion induces kidney cGMP axis upregulation: consequences on basal and acutely damaged renal function. Mol Med. 2016;21:873\u201385.","journal-title":"Mol Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03188-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03188-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03188-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:04:37Z","timestamp":1679627077000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03188-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3188"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03188-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2055972\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study was performed in accordance with the National Institutes of Heath Guidelines on the Care and Use of Laboratory Animals, The presented experimental protocols with the standards for animal care were approved by Local Experimental Animal Ethics and the Research Ethics Committee Acts at King Saud University in Saudi Arabia (approval no. KSU-SE-19\u201361). This study is reported in accordance with ARRIVE guidelines. Additionally, the authors working with animals in this study have successfully completed the CITI Program course of Animal Biosafety.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"It is Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}